| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | -$13.8M | -36K | -0.65% | $383.44 | 5.49M | Feb 21, 2024 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | -$39.6M | -100K | -1.82% | $395.98 | 5.39M | Feb 22, 2024 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $379.96 to $386.56. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.86 to $401.45. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |